• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
79,454.47 -880.34
( -1.10%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,380.81 245.84
(0.60%)
Dow Jones
5,684.33 32.05
(0.57%)
Hang Seng
37,492.25 563.62
(1.53%)
Nikkei 225
8,554.80 23.19
(0.27%)
Forex
USD-INR
84.70 0.29
(0.35%)
EUR-INR
96.08 0.41
(0.42%)
GBP-INR
112.96 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
98.3315118
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
134.52
423770.54
EPS(TTM)
Face Value()
Div & Yield %
13.13
1
0.76
 

hero motocorp ltd
Ashok Leyland Ltd - Board Meeting Intimation for Considering And Approval Of Standalone And Consolidated Audited Financials For The Year Ended March 31 2025 And Recommendation Of Final Dividend If Any For The Approval Of The Shareholders
May 08,2025
Ashok Leyland Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve standalone and consolidated audited financials for the year ended March 31 2025 and recommendation of final dividend if any for the approval of the shareholders